X |
Filing Date |
Trade Date |
Ticker |
Company Name | Industry | Ins |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12 M | 2026-10-15 | BPRE | Bluerock Private Real Estate Fund | Closed-End Funds | 3 | P - Purchase | $12.68 | +2,494,569 | 2,508,335 | >999% | +$31,624,766 | |||||
| 8 DM | 2026-10-16 | FUL | Fuller H B Co | Adhesives & Sealants | 8 | P - Purchase | $49.71 | +22,596 | 46,434 | +95% | +$1,123,318 | |||||
| 7 M | 2026-09-25 | PAM | Pampa Energy Inc. | Electric Services | 3 | P - Purchase | $11.40 | +4,517,122 | 38,946,736 | +13% | +$51,509,548 | |||||
| 13 D | 2026-10-15 | BORR | Borr Drilling Ltd | Drilling Oil & Gas Wells | 3 | P - Purchase | $4.44 | +12,870,500 | 42,087,559 | +44% | +$57,144,458 | |||||
| 3 | 2026-09-22 | DUOT | Duos Technologies Group, Inc. | Prepackaged Software | 2 | P - Purchase | $9.00 | +24,264 | 1,373,773 | +2% | +$218,401 | |||||
| 26 M | 2026-09-18 | BBD | Bank Bradesco | State Commercial Banks | 22 | P - Purchase | $17.45 | +5,760,088 | 24,937,122 | +30% | +$100,491,354 | |||||
| 4 M | 2026-10-14 | INBX | Inhibrx Biosciences, Inc. | Biological Products, (No Diagnostic Substances) | 2 | P - Purchase | $100.54 | +47,540 | 1,197,517 | +4% | +$4,779,777 | |||||
| 2 | 2026-10-07 | ONMD | Onemednet Corp | Commercial Physical & Biological Research | 2 | P - Purchase | $5.72 | +174,884 | 3,011,610 | +6% | +$999,999 | |||||
| 2 D | 2026-10-13 | RTSN | Retension Pharmaceuticals, Inc. | Pharmaceutical Preparations | 2 | P - Purchase | $12.00 | +30,800 | 486,924 | +7% | +$369,600 | |||||
| 9 | 2026-09-08 | GME | Gamestop Corp. | Computer & Computer Software Stores | 5 | P - Purchase | $23.38 | +4,238,027 | 43,304,772 | +11% | +$99,078,947 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-10-19 | XGN | Exagen Inc. | Chernett Jorey | 10% | P - Purchase | $7.46 | +14,000 | 2,618,540 | +1% | +$104,440 | ||||||
2026-10-19 | NBIS | Nebius Group N.V. | Grimme Arne | Dir | P - Purchase | $169.99 | +148 | 6,329 | +2% | +$25,159 | ||||||
| D | 2026-10-16 | IAM | Iambic Therapeutics, Inc. | Rachlin Evan Lockwood | Dir | P - Purchase | $16.00 | +718,750 | 57,754 | -109% | +$11,500,000 | |||||
2026-10-15 | DSM | Bny Mellon Strategic Municipal Bond Fund, Inc. | Saba Capital Management, L.P. | 10% | P - Purchase | $5.24 | +13,762 | 5,193,203 | 0% | +$72,113 | ||||||
| M | 2026-10-09 | EP | Empire Petroleum Corp | Mulacek Phil E | Dir, 10% | P - Purchase | $3.19 | +97,981 | 11,687,503 | +1% | +$312,811 | |||||
2026-10-15 | GF | New Germany Fund Inc | Saba Capital Management, L.P. | 10% | P - Purchase | $10.30 | +16,577 | 3,775,999 | 0% | +$170,743 | ||||||
2026-10-15 | ECF | Ellsworth Growth & Income Fund Ltd | Saba Capital Management, L.P. | 10% | P - Purchase | $11.62 | +9,969 | 1,754,599 | +1% | +$115,840 | ||||||
| D | 2026-10-19 | CTY | City Therapeutics, Inc. | Arch Venture Partners Xii, LLC | 10% | P - Purchase | $18.00 | +170,000 | 13,692,507 | +1% | +$3,060,000 | |||||
| M | 2026-10-15 | SNES | Senestech, Inc. | Glenbrook Capital Management | 10% | P - Purchase | $0.72 | +983,804 | 3,568,392 | +38% | +$706,057 | |||||
| D | 2026-10-19 | CTY | City Therapeutics, Inc. | Nelsen Robert | Dir, 10% | P - Purchase | $18.00 | +170,000 | 13,692,507 | +1% | +$3,060,000 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-10-09 | EP | Empire Petroleum Corp | Mulacek Phil E | Dir, 10% | P - Purchase | $3.19 | +97,981 | 11,687,503 | +1% | +$312,811 | |||||
| M | 2026-10-15 | SNES | Senestech, Inc. | Glenbrook Capital Management | 10% | P - Purchase | $0.72 | +983,804 | 3,568,392 | +38% | +$706,057 | |||||
| D | 2026-10-15 | CNXU | Conexeu Sciences Inc. | Purcell Lynn Sebastian | Dir, 10% | P - Purchase | $3.00 | +166,666 | 3,118,514 | +6% | +$499,998 | |||||
| M | 2026-10-15 | API | Agora, Inc. | Zhao Bin | CEO | P - Purchase | $4.44 | +17,345 | 85,613,435 | 0% | +$76,930 | |||||
2026-10-09 | ELTP | Elite Pharmaceuticals Inc /Nv/ | Dash Barry H | Dir | P - Purchase | $0.26 | +100,000 | 3,365,555 | +3% | +$25,980 | ||||||
| M | 2026-10-14 | GRCE | Grace Therapeutics, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $1.92 | +71,065 | 2,944,354 | +2% | +$136,178 | |||||
2026-10-16 | ZONE | Zone Frontier Inc. | Hassen Tyler Lewis | CEO | P - Purchase | $0.11 | +500,000 | 4,500,000 | +13% | +$55,150 | ||||||
2026-10-16 | SAFX | Xcf Global, Inc. | Eeme Energy Spv I, LLC | 10% | P - Purchase | $1.19 | +119,397,858 | 228,897,418 | +109% | +$142,083,451 | ||||||
| M | 2026-10-14 | BYRN | Byrna Technologies Inc. | Roth Adam L. | Dir | P - Purchase | $4.69 | +15,000 | 19,379 | +343% | +$70,375 | |||||
| D | 2026-10-14 | BORR | Borr Drilling Ltd | Snowling Harvey Edward | COO | P - Purchase | $4.91 | +300,000 | 198,444 | -295% | +$1,473,000 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-10-15 | GRAB | Grab Holdings Ltd | Oey Peter Henry | CFO | S - Sale | $2.98 | -50,000 | 6,753,470 | -1% | -$148,950 | ||||||
| M | 2026-10-16 | LIND | Lindblad Expeditions Holdings, Inc. | Lindblad Sven-Olof | Dir, 10% | S - Sale | $34.51 | -162,685 | 10,524,517 | -2% | -$5,614,448 | |||||
| M | 2026-10-15 | TALO | Talos Energy Inc. | Control Empresarial De Capitales S.A. De C.V. | Add'l Rep. Persons-see Ex.99-1, 10% | S - Sale | $17.19 | -2,752,000 | 26,641,590 | -9% | -$47,307,541 | |||||
| M | 2026-10-15 | BETA | Beta Technologies, Inc. | Clark Kyle | SEE REMARKS | S - Sale | $18.34 | -30,000 | 7,469,504 | 0% | -$550,190 | |||||
2026-10-15 | PLTR | Palantir Technologies Inc. | Moore Alexander D. | Dir | S - Sale | $197.99 | -16,000 | 1,047,095 | -2% | -$3,167,867 | ||||||
| M | 2026-10-15 | CRWD | Crowdstrike Holdings, Inc. | Kurtz George | Pres, CEO | S - Sale | $236.92 | -20,000 | 7,841,504 | 0% | -$4,738,401 | |||||
2026-10-16 | CRWD | Crowdstrike Holdings, Inc. | Flower Johanna | Dir | S - Sale | $230.05 | -9,896 | 296,288 | -3% | -$2,276,597 | ||||||
| D | 2026-10-16 | WSE | Wise Group Plc | Sinha Harsh | CTO | S - Sale+OE | $11.75 | -42,324 | 979,030 | -4% | -$497,307 | |||||
| D | 2026-10-16 | WSE | Wise Group Plc | Peiris Nilan | Chief Product Officer | S - Sale+OE | $11.75 | -58,262 | 3,642,228 | -2% | -$684,579 | |||||
2026-10-19 | NET | Cloudflare, Inc. | Ledbetter Carl | Dir | S - Sale | $304.40 | -5,000 | 888,514 | -1% | -$1,521,994 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-10-19 | VTEX | Vtex | Do Carmo Thomaz Junior Geraldo | CEO | S - Sale | $4.09 | -4,808 | 1,251,714 | 0% | -$19,665 | ||||||
2026-10-19 | VTEX | Vtex | Gomide De Faria Mariano | CEO | S - Sale | $4.10 | -4,808 | 1,542,192 | 0% | -$19,713 | ||||||
2026-10-16 | VTEX | Vtex | Gomes Andre Spolidoro Ferreira | Chief Strategy Officer | S - Sale | $4.19 | -6,000 | 330,231 | -2% | -$25,140 | ||||||
2026-10-16 | ISBA | Isabella Bank Corp | Bourland Jill | Dir | P - Purchase | $36.71 | +8 | 5,933 | 0% | +$300 | ||||||
2026-10-19 | XGN | Exagen Inc. | Chernett Jorey | 10% | P - Purchase | $7.46 | +14,000 | 2,618,540 | +1% | +$104,440 | ||||||
2026-10-16 | KEYS | Keysight Technologies, Inc. | Li Jeffrey K | SVP, Secretary | F - Tax | $331.21 | -1,479 | 33,067 | -4% | -$489,860 | ||||||
2026-10-16 | KEYS | Keysight Technologies, Inc. | Juskie Jo Ann | SVP | F - Tax | $331.21 | -1,375 | 11,111 | -11% | -$455,414 | ||||||
2026-10-19 | NBIS | Nebius Group N.V. | Grimme Arne | Dir | P - Purchase | $169.99 | +148 | 6,329 | +2% | +$25,159 | ||||||
| D | 2026-10-16 | IONS | Ionis Pharmaceuticals Inc | Devers Shannon L. | EVP, Chief HR Ofc | S - Sale+OE | $43.54 | -1,357 | 17,811 | -7% | -$59,082 | |||||
| D | 2026-10-16 | IONS | Ionis Pharmaceuticals Inc | Swayze Eric | EVP Research | S - Sale+OE | $43.54 | -53 | 22,149 | 0% | -$2,308 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |